Cancer Management and Research
Volume 13, 2021 - Issue
Open access
166
Views
9
CrossRef citations to date
0
Altmetric
Original Research
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
Danijel Sikic1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, GermanyCorrespondence[email protected]
, Helge Taubert1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germanyhttps://orcid.org/0000-0002-9077-1727
, Johannes Breyer3 Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany
, Markus Eckstein2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany;4 Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
, Veronika Weyerer2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany;4 Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
, Bastian Keck1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
, Jennifer Kubon1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
, Wolfgang Otto3 Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany
, Thomas S Worst5 Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
, Maximilian C Kriegmair5 Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
, Philipp Erben5 Department of Urology and Urosurgery, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
, Arndt Hartmann2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany;4 Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
, Bernd Wullich1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germanyhttps://orcid.org/0000-0002-0665-6604
, Ralph M Wirtz6 STRATIFYER Molecular Pathology GmbH, Cologne, Germany
& Sven Wach1 Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany;2 Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
show all
Pages 6567-6578
|
Published online: 20 Aug 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.